Dinakar Murthi, MD
Orthopaedic Surgery · Nashua, NHNPI 1346297801
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Bioventus LLC at 26.4% of the total. That places this record below the midpoint for orthopaedic surgery clinicians in NH, where the typical reported total is $2,654.
Across 9 payments — averaging $22.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bioventus LLC$53
- Endo USA, Inc.$30
- Pacira Pharmaceuticals Incorporated$26
- Solventum Corporation$25
- Ferring Pharmaceuticals Inc.$22
- Vertex$17
- plus $29 from 2 others
What the payments were for
- Food & beverage$202100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bioventus LLC | 2 | $53 |
| Endo USA, Inc. | 1 | $30 |
| Pacira Pharmaceuticals Incorporated | 1 | $26 |
| Solventum Corporation | 1 | $25 |
| Ferring Pharmaceuticals Inc. | 1 | $22 |
| Vertex | 1 | $17 |
| Fidia Pharma USA Inc. | 1 | $16 |
| UCB, Inc. | 1 | $13 |
How this compares
$202 in reported general payments places this provider in the 15th percentile of 141 orthopaedic surgery providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium ErDiclofenac Sodium | 88 | $2,123 |
| Methylprednisolone | 227 | $1,158 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 56 | $586 |
| Orphenadrine Citrate ErOrphenadrine Citrate | 22 | $555 |
| Cyclobenzaprine Hcl | 64 | $439 |
| Prednisone | 97 | $259 |
| Tizanidine Hcl | 44 | $256 |
| Methocarbamol | 23 | $235 |
| Meloxicam | 32 | $207 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $153 |
| Gabapentin | 12 | $120 |
| Oxycodone Hcl | 11 | $55 |
| Lorazepam | 30 | $43 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Nashua
- David RichardsNashua$122K
- Christian KlareNashua$88K
- Matthew WilkeningNashua$79K
- Thomas FortneyNashua$54K
- Peter EyvazzadehNashua$19K
- Anand PadmanabhaNashua$16K
- Bryan BeanNashua$11K
- Andrew GarberNashua$9K
- Jason SmoakNashua$8K
- James BargerNashua$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.